UMN Pharma Inc.

UMN Pharma Inc.
Stock Exchange Tokyo Stock Exchange
EPS
JPY52.29
Market Cap
JPY4.83 B
Shares Outstanding
15.3 M
Public Float
11.73 M

Profile

Address
4-2-3 Gosyonoyumoto
Akita Akita 010
Japan
Employees -
Website http://www.umnpharma.com
Updated 07/08/2019
UMN Pharma, Inc. engages in the development, manufacture, and sale of biopharmaceuticals. It develops vaccines targeting influenza, norovirus, and rotavirus. The company was founded by Masahiro Michishita and Shuichi Kanazashi on April 20, 2004 and is headquartered in Akita, Japan.

Financials

View All

Tatsuyoshi Hirano
Chairman & President
Hiroyuki Hashimoto
Director & Manager-Finance